Tempest Therapeutics, Inc. Annual Depreciation in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tempest Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2017 to 2023.
  • Tempest Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $155K, a 86.7% increase year-over-year.
  • Tempest Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $416K, a 33.5% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Depreciation for 2023 was $381K, a 40.3% decline from 2022.
  • Tempest Therapeutics, Inc. annual Depreciation for 2022 was $638K, a 70.6% increase from 2021.
  • Tempest Therapeutics, Inc. annual Depreciation for 2021 was $374K, a 10.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $381K -$257K -40.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 $638K +$264K +70.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 $374K +$35K +10.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $339K +$242K +249% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $97K +$65K +203% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $32K +$4K +14.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 $28K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.